Fuller & Thaler discloses 4.67% Integra LifeSciences (IART) stake

Rhea-AI Filing Summary

Integra LifeSciences Holdings Corp received an amended ownership report from institutional investor Fuller & Thaler Asset Management, Inc. as of 12/31/2025. Fuller & Thaler reports beneficial ownership of 3,636,359.96 shares of Integra common stock, representing 4.67% of the class.

The firm has sole power to vote 3,583,652.96 shares and sole power to dispose of 3,636,359.96 shares, with no shared voting or dispositive power. Fuller & Thaler certifies the position is held in the ordinary course of business and not for the purpose of changing or influencing control of Integra.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

INTEGRA LIFESCIENCES HOLDINGS CORP

(Name of Issuer)

Common Stock

(Title of Class of Securities)

457985208

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 457985208

1

Names of Reporting Persons

Fuller & Thaler Asset Management, Inc.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

CALIFORNIA

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 3,583,652.96
6	Shared Voting Power 0.00
7	Sole Dispositive Power 3,636,359.96
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

3,636,359.96

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.67 %

12

Type of Reporting Person (See Instructions)

IA

SCHEDULE 13G

Item 1.
(a)	Name of issuer: INTEGRA LIFESCIENCES HOLDINGS CORP
(b)	Address of issuer's principal executive offices: 1100 CAMPUS ROAD, PRINCETON, NJ, 08540
Item 2.
(a)	Name of person filing: Fuller & Thaler Asset Management, Inc.
(b)	Address or principal business office or, if none, residence: 411 Borel Avenue, Suite 300, San Mateo, CA 94402
(c)	Citizenship: California corporation
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 457985208
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 3,636,359.96
(b)	Percent of class: 4.67 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 3,583,652.96
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 3,636,359.96
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Fuller & Thaler Asset Management, Inc.

Signature:	/s/ Hanna Zanoni
Name/Title:	Chief Compliance Officer
Date:	02/17/2026

FAQ

What stake does Fuller & Thaler hold in Integra LifeSciences (IART)?

Fuller & Thaler beneficially owns 3,636,359.96 Integra shares, equal to 4.67% of the common stock. The firm reports sole voting power over most of these shares and sole dispositive power over the full amount.

What type of filing did Fuller & Thaler submit for Integra LifeSciences (IART)?

The firm submitted an amended Schedule 13G/A, which is a passive ownership report for large shareholders. It reflects Fuller & Thaler’s position in Integra common stock as of December 31, 2025.

Does Fuller & Thaler seek to influence control of Integra LifeSciences (IART)?

No. Fuller & Thaler certifies the Integra shares were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the company.

How much voting power does Fuller & Thaler report in Integra LifeSciences (IART)?

Fuller & Thaler reports sole voting power over 3,583,652.96 shares of Integra common stock and no shared voting power. It also holds sole dispositive power over 3,636,359.96 shares.

Why does Fuller & Thaler file as an investment adviser for Integra (IART)?

Fuller & Thaler files as an investment adviser under Rule 13d-1(b). This status reflects its role managing client assets while reporting beneficial ownership of Integra LifeSciences common stock.

Is Fuller & Thaler’s ownership in Integra LifeSciences (IART) above 5%?

No. Fuller & Thaler reports ownership of 4.67% of Integra’s common stock, which is less than 5% of the outstanding class as disclosed in the filing.